Developing new radiotracers
20 Sep 2017
Developing new radiotracers
What to expect from a PET scan
ESMO 2017 highlights on managing difficult to treat cancers
Patient empowerment and quality of life
Nivolumab vs ipilimumab for high risk melanoma patients
Patient perceptions of chemotherapy side effects differ over time and treatment
ABP 980, a biosimilar antibody for trastuzumab
New strategies in melanoma care
Real-world productivity of advanced gastric cancer patients
Abemaciclib for advanced breast cancer
Comment: MONARCH 3 trial: Abemaciclib for advanced breast cancer
CheckMate 214: nivolumab ipilimumab vs sunitinib for advanced or metastatic renal cell carcinoma